How to Buy Eyepoint Pharmaceuticals Stock
Eyepoint Pharmaceuticals Inc
EyePoint Pharmaceuticals, Inc. , a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom.
Eyepoint Pharmaceuticals stock last closed at $5.90, up 3.96% from the previous day, and has decreased 65.19% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Eyepoint Pharmaceuticals stock is currently +50.9% from its 52-week low of $3.91, and -72.24% from its 52-week high of $21.26.
As of Apr 21, 2025, there are 68.73M EYPT shares outstanding. The market capitalization of EYPT is $405.50M. In the last 24 hours, 510,477 EYPT shares were traded.
How to Buy Eyepoint Pharmaceuticals Stock
Wondering how to invest in Eyepoint Pharmaceuticals stock? Here's how.
- Figure out where to buy Eyepoint Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Eyepoint Pharmaceuticals stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Choose your method of payment and add your information.
- Evaluate Eyepoint Pharmaceuticals stock: The Eyepoint Pharmaceuticals ticker symbol is EYPT. Is Eyepoint Pharmaceuticals stock a good investment? Should you buy shares of EYPT? How do EYPT's underlying business fundamentals look? Do top analysts think Eyepoint Pharmaceuticals is a good buy? Why has EYPT's stock price moved recently? (Hint: Our stock market research tools can help you figure out if EYPT is a good stock to buy).
- Make your EYPT buy order: Decide if you will purchase EYPT shares at the current market price or use a limit order to buy EYPT stock at a given price.
- Get updates on your EYPT investment: Create a watchlist to get the latest news on your new investment in Eyepoint Pharmaceuticals shares.
Step 1: Figure out where to buy Eyepoint Pharmaceuticals stock
You need an online brokerage account in order to access the NASDAQ market and buy EYPT stock.
Our favorite brokerage: eToro
We believe that eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal information so you are able to buy EYPT today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to start your new brokerage account.
- Send your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you've finished signing up on a good stock buying app, you can securely and quickly fund your account:
Watch the tutorial below to see the process of transferring funds into your new investment account.
Step 4: Evaluate Eyepoint Pharmaceuticals stock
Once you have figured out the best place to buy Eyepoint Pharmaceuticals stock, it's important to evaluate their stock prior to buying, so you actually comprehend the risk and opportunity.
Eyepoint Pharmaceuticals stock at a glance
Eyepoint Pharmaceuticals Due Diligence Checks
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on EYPT's stock page.
Is EYPT stock overvalued?
You can use many financial metrics, analyses, models, and charts to gauge EYPT's intrinsic value.
Using relative valuations metrics:
- EYPT may be undervalued based on its P/B ratio of 1.21x, relative to Biotechnology industry P/B ratio of 4.04x
You can do additional valuation research on EYPT's stock here.
EYPT Financials at a glance
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the EYPT balance sheet.
- There are more short-term assets than short-term liabilities on the EYPT balance sheet.
- EYPT has cash burn of 130278000. It has enough cash and short-term investments to cover this for at least one year.
- EYPT has a low debt to equity ratio of 0.24.
- Total EYPT debt is lower than 5 years ago, relative to shareholder equity.
- EYPT has $371.06M in cash and short term investments. This is enough to cover its annual cash burn of $130.28M.
Negative Financial Indicators:
- EYPT profit margin has gone down from -153.8% to -302.4% in the past year.
Do Wall Street analysts think it's a good time to buy EYPT stock
Out of 3 Wall Street analysts who monitor EYPT, the consensus analyst rating on EYPT is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Eyepoint Pharmaceuticals stock forecast page.
EYPT Trading Indicators
EYPT Performance Metrics
Last year, EYPT revenue was $43.27M. Over the past five year, EYPT's revenue has grown by 16.27% per year. This was slower than the Biotechnology industry average of 44.31%.
You can analyze EYPT's earnings and revenue performance here.
Latest Insiders Trades at EYPT
In the past year, executives and large shareholders at EYPT have bought more shares than they have sold.
Jay S. Duker, President and CEO of EYPT, was the latest EYPT insider to sell. They sold $123,100.00 worth of EYPT stock on Mar 19, 2025.
Learn more about who owns EYPT shares here.
Can I get consistent income from EYPT stock?
No, Eyepoint Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about EYPT?
One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your EYPT buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, use a limit order.
Press the Open button and your broker will place your order.
If you want additional assistance investing in stocks on eToro, click the helpful video below:
Step 6: Get updates on your EYPT investment
Now that you own some EYPT shares, you'll want to stay up-to-date on your shares.
Create a watchlist to track the most important metrics related to your EYPT stock.
EYPT Feed
How to Buy Stock in Eyepoint Pharmaceuticals
To summarize, here are the 6 steps you need to take to buy Eyepoint Pharmaceuticals stock right now:
- Figure out where to buy Eyepoint Pharmaceuticals stock
- Sign up for a brokerage account
- Put funds into your investment account
- Evaluate Eyepoint Pharmaceuticals stock
- Make your EYPT buy order
- Get updates on your EYPT investment
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your new investment in Eyepoint Pharmaceuticals, click the button below.
More Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.